Esophageal cancer

Practical Gastroenterology and Hepatology: Esophagus and Stomach

Volumn , Issue , 2010, Pages 315-324

  Smith, Michael S ^a   Lightdale, Charles J ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881613751     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (18)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Engel LS, Chow WH, Vaughan TL, et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1404-13.
3. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005; 143: 199-211.
4. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 2004; 99: 582-8.
5. Terry P, Lagergren J, Ye W, et al. Inverse association between intake of cereal fiber and the risk of gastric cardia cancer. Gastroenterology 2001; 120: 387-91.
6. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1997; 89: 1247-84.
7. Holscher AH, Bollschweiler E, Schneider PM, et al. Prognosis of early esophageal cancer: comparison between adeno-and squamous cell carcinoma. Cancer 1995; 76: 178-86.
8. Graham DY, Schwartz JT, Cain GD, et al. Prospective evaluation of biopsy number in the diagnosis of esophageal and gastric carcinoma. Gastroenterology 1982; 82: 228-31.
9. Greene FL, ed. AJCC Cancer Staging Manual, 6th edn. New York: Springer-Verlag, Inc., 2002.
10. Rosch T. Endosonographic staging of esophageal cancer: a review of literature results. Gastrointest Endosc Clin N Am 1995; 5: 537-47.
11. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology™: Esophageal Cancer, V.1, 2009, Accessed via http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
12. Orringer MB, Marshall B, Chang AC, et al. Two thousand transhiatal esophagectomies: changing trends, lessons learned. Ann Surg 2007; 246: 363-72.
13. Griffin SM, Shaw IH, Dresner SM. Early complications after Ivor Lewis subtotal esophagectomy with two-field lymphad-enectomy: risk factors and management. J Am Coll Surg 2002; 194: 285-97.
14. Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346: 1128-37.
15. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
16. Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 281: 1623-7.
17. Boyce HW Jr. Palliation of dysphagia of esophageal cancer by endoscopic lumen restoration techniques. Cancer Control 1999; 6: 73.
18. Bethge N, Sommer A, Vakil N. A prospective trial of self-expanding metal stents in the palliation of malignant esophageal strictures near the upper esophageal sphincter. Gastrointest Endosc 1997; 45: 300-3.